1. Home
  2. CPIX vs CELU Comparison

CPIX vs CELU Comparison

Compare CPIX & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • CELU
  • Stock Information
  • Founded
  • CPIX 1999
  • CELU 2016
  • Country
  • CPIX United States
  • CELU United States
  • Employees
  • CPIX N/A
  • CELU N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPIX Health Care
  • CELU Health Care
  • Exchange
  • CPIX Nasdaq
  • CELU Nasdaq
  • Market Cap
  • CPIX 40.1M
  • CELU 42.2M
  • IPO Year
  • CPIX 2009
  • CELU N/A
  • Fundamental
  • Price
  • CPIX $3.44
  • CELU $3.25
  • Analyst Decision
  • CPIX
  • CELU
  • Analyst Count
  • CPIX 0
  • CELU 0
  • Target Price
  • CPIX N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • CPIX 81.2K
  • CELU 584.0K
  • Earning Date
  • CPIX 08-05-2025
  • CELU 05-08-2025
  • Dividend Yield
  • CPIX N/A
  • CELU N/A
  • EPS Growth
  • CPIX N/A
  • CELU N/A
  • EPS
  • CPIX N/A
  • CELU N/A
  • Revenue
  • CPIX $41,083,299.00
  • CELU $54,220,000.00
  • Revenue This Year
  • CPIX N/A
  • CELU $23.29
  • Revenue Next Year
  • CPIX N/A
  • CELU N/A
  • P/E Ratio
  • CPIX N/A
  • CELU N/A
  • Revenue Growth
  • CPIX 5.82
  • CELU 138.11
  • 52 Week Low
  • CPIX $1.04
  • CELU $1.00
  • 52 Week High
  • CPIX $7.25
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 46.28
  • CELU 62.00
  • Support Level
  • CPIX $3.25
  • CELU $2.95
  • Resistance Level
  • CPIX $3.97
  • CELU $3.44
  • Average True Range (ATR)
  • CPIX 0.36
  • CELU 0.41
  • MACD
  • CPIX 0.07
  • CELU 0.05
  • Stochastic Oscillator
  • CPIX 45.36
  • CELU 52.99

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: